InPharmation
Mark Duxon

Advancing Preclinical Science for Next-Gen Therapies

Mark Duxon - CEO | September 2025

Be the first to know. Get InPharmation straight to your inbox.

Sign up to receive the latest scientific advancements by email.

Emails with our latest study results and news, from time to time. Unsubscribe anytime. See our Privacy Policy.